Lenovo reported exceptional Q4 FY2025/26 results (ending March 2026) with record quarterly revenue of $21.6B, up 27%...
Lenovo reported exceptional Q4 FY2025/26 results (ending March 2026) with record quarterly revenue of $21.6B, up 27% YoY, and adjusted net income doubling to $559M (CNBC). AI-related revenue surged 84% YoY to account for 38% of total revenue, driven by AI PCs, AI servers with GPUs, and enterprise AI services (Bloomberg; Lenovo IR). Full-year revenue reached $69B, a new record. The company aims to reach $100B revenue within two years, betting heavily on AI. Shares surged 19.3% on the day to near all-time highs. The strong AI-related growth indicates sustained demand for AI infrastructure, including GPU servers and AI-enabled devices, which may benefit upstream suppliers like NVIDIA and AMD in future quarters.
0992.HK is already up +147% over the recent 30-90 day window.
signal brief
Lenovo reported exceptional Q4 FY2025/26 results (ending March 2026) with record quarterly revenue of $21.6B, up 27% YoY, and adjusted net income doubling to $559M (CNBC). AI-related revenue surged 84% YoY to account for 38% of total revenue, driven by AI PCs, AI servers with GPUs, and enterprise AI services (Bloomberg; Lenovo IR). Full-year revenue reached $69B, a new record. The company aims to reach $100B revenue within two years, betting heavily on AI. Shares surged 19.3% on the day to near all-time highs. The strong AI-related growth indicates sustained demand for AI infrastructure, including GPU servers and AI-enabled devices, which may benefit upstream suppliers like NVIDIA and AMD in future quarters.
evidence
- https://www.bloomberg.com/news/videos/2026-05-22/the-china-show-5-22-2026-videoweb
- https://www.bloomberg.com/news/articles/2026-05-22/lenovo-shares-surge-13-after-earnings-show-ai-driven-growthweb
- https://www.cnbc.com/2026/05/22/lenovo-shares-jump-15percent-on-record-earnings-as-ai-revenue-nearly-doubles.htmlweb
- https://investor.lenovo.comweb
Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.